Ocular Hypertension Treatment Market Overview by Rising Trends and Demand 2030

Comments ยท 27 Views

The expected CAGR of global ocular hypertension treatment market is tend to be around 3% in the mentioned forecast period. The market was valued at USD 5.13 billion in 2022, and it would grow upto USD 6.5 billion by 2030.

The global Ocular Hypertension Treatment Market research report 2030, as published by Data bridge Market Research, provides insights into the current global outlook and key regions, examining Major Players, Countries, Product Types, and end industries. It focuses on top players in the global market and categorizes the market based on several parameters.

This Ocular Hypertension Treatment market research report identifies the competitive landscape of industries, offering a comprehensive understanding of international competition. The study outlines the anticipated growth of the global market during forecast period. Compiled with a blend of static and dynamic perspectives, this research report captures the essence of the businesses views.

The expected CAGR of global ocular hypertension treatment market is tend to be around 3% in the mentioned forecast period. The market was valued at USD 5.13 billion in 2022, and it would grow upto USD 6.5 billion by 2030.

Top Companies in the Global Ocular Hypertension Treatment Market:
Aerie Pharmaceuticals, Inc. (U.S.), Abbvie, Inc (U.S.), Angelini Pharma S.p.a.(Italy), Chong Kun Dang pharmaceutical Corp (South Korea), Laboratorios Sophia (Mexico), Lee Pharma Ltd (Hong Kong), Neurim Pharmaceuticals LTD (Israel), Nicox (France), Novartis AG (Switzerland), Ocular Therapeutix, Inc. (U.S.), Sylentis, S.A (Spain), Taejoon Pharm (South Korea), Takeda Pharmaceutical Company Limited (Japan), Bausch Health Companies Inc. (Canada.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), among others.

Market Segmentation:

The global ocular hypertension treatment market is segmented on the basis of type, route of administration , drug type, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Intraocular Hypertension

• Glaucoma

Route of Administration

• Oral

• Parenteral

• Others

Drug Type

• Prescription

• Over the Counter

End User

• Hospitals

• Homecare

• Specialty Clinics

• Others

Distribution Channel

• Hospital Pharmacy

• Online Pharmacy

• Retail Pharmacy

Geographically, the detailed analysis of consumption, revenue, market share, and growth rate of the following regions:

– Middle East and Africa (South Africa, Saudi Arabia, UAE, Israel, Egypt, etc.)

– North America (United States, Mexico & Canada)

– South America (Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, etc.)

– Europe (Turkey, Spain, Turkey, Netherlands Denmark, Belgium, Switzerland, Germany, Russia UK, Italy, France, etc.)

– Asia-Pacific (Taiwan, Hong Kong, Singapore, Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia).

Asia-Pacific has been witnessing a positive growth for global ocular hypertension treatment market throughout the forecasted period due to the highest number of geriatric and vulnerable populations.

North America dominates the market due to the increase in research & development activities for the development of novel therapies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Browse The Report Description:

https://www.databridgemarketresearch.com/reports/global-ocular-hypertension-treatment-market

Market Dynamics

Drivers

• Increase in elderly population

The global ocular hypertension treatment market is projected to witness a heavy growth rate during the forecast period driven by the factor of an aging population. The growing demand in the global ocular hypertension treatment market is the replication of the rising elderly population, as people aged over 60 years normally develop conditions wherein the eyes have reduced elasticity, affecting the normal functioning. This boost the market growth.

• Advanced technological advancements

Increasing technological advancements associated with the ocular hypertension treatment and diagnostics are boosting the growth of the market. Technologies such as medical imaging, selective laser trabeculoplasty (SLT), visual fields, micro-invasive glaucoma surgery (MIGS), optical coherence tomography (OCT), and progression analysis software will increase patient preference. Moreover, the market size will increase if laser therapies are combined with medications to treat glaucoma as the first-line therapy. This boosts the market growth

Opportunities

• Rising strategic initiatives

The strategic initiatives that major key players undertake is projected to increase the market growth. For instance, in June 2022, Novartis Pharmaceuticals Corporation announced the acquisition of Kedalion Therapeutics for its novel AcuStream technology. This acquisition pushed Novartis to boost its ophthalmic product portfolio. In addition to this, in June 2022 Amring Pharmaceuticals Inc. announced that its generic Timolol Maleate Ophthalmic Solution has received approval from the U.S FDA. Timolol Maleate Ophthalmic Solution is a preservative-free solution and is recommended in the treatment of open-angle glaucoma and ocular hypertension.

• Increasing R&D activities

Increasing research and development activities and expenditure by top market players is expected to increase the market growth during the projected period. For an instance, Alcon, a leader in eye care spent USD 842 million on R&D in 2021 as compared to USD 673 million in 2020. Alcon provides an extensive range of products such as contact lenses, cataracts, and glaucoma products. Thus, all these increasing healthcare expenditures create many market growth opportunities.

Browse Other Trending Reports:

Global Angular Cheilitis Treatment Market – Industry Trends and Forecast to 2030
https://www.databridgemarketresearch.com/reports/global-angular-cheilitis-treatment-market

Global Automated Feeding Systems Market - Industry Trends and Forecast to 2029
https://www.databridgemarketresearch.com/reports/global-automated-feeding-systems-market

Global Curved Televisions Market - Industry Trends and Forecast to 2029
https://www.databridgemarketresearch.com/reports/global-curved-televisions-market

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact Us:
Data Bridge Market Research
Tel: +1-888-389.80-2818 | +44 208 089 1725 | +852 8192 7475
Email: 
Corporatesales@databridgemarketresearch.com

Comments